188 related articles for article (PubMed ID: 15735039)
1. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C
Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells.
Bug G; Gül H; Schwarz K; Pfeifer H; Kampfmann M; Zheng X; Beissert T; Boehrer S; Hoelzer D; Ottmann OG; Ruthardt M
Cancer Res; 2005 Apr; 65(7):2537-41. PubMed ID: 15805245
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid enhances the engraftability of human umbilical cord blood hematopoietic stem cells expanded under serum-free conditions.
Seet LF; Teng E; Lai YS; Laning J; Kraus M; Wnendt S; Merchav S; Chan SL
Eur J Haematol; 2009 Feb; 82(2):124-32. PubMed ID: 19067743
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
[TBL] [Abstract][Full Text] [Related]
5. Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.
Zimran E; Papa L; Djedaini M; Patel A; Iancu-Rubin C; Hoffman R
Stem Cells Transl Med; 2020 Apr; 9(4):531-542. PubMed ID: 31950644
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 3 modulates the expansion of human hematopoietic stem cells.
Elizalde C; Fernández-Rueda J; Salcedo JM; Dorronsoro A; Ferrin I; Jakobsson E; Trigueros C
Stem Cells Dev; 2012 Sep; 21(14):2581-91. PubMed ID: 22455388
[TBL] [Abstract][Full Text] [Related]
7. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
Shaw PH; Olszewski M; Kletzel M
J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and molecular signatures of cord blood CD34(+) cells treated with histone deacetylase inhibitors.
Gajzer D; Ross J; Winder L; Navada S; Zhang W; Silverman L; Chaurasia P
Vox Sang; 2016 Jan; 110(1):79-89. PubMed ID: 26084882
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid affects the engraftment of TPO-expanded cord blood cells in NOD/SCID mice.
Vulcano F; Milazzo L; Ciccarelli C; Barca A; Agostini F; Altieri I; Macioce G; Di Virgilio A; Screnci M; De Felice L; Giampaolo A; Hassan HJ
Exp Cell Res; 2012 Feb; 318(4):400-7. PubMed ID: 22166516
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors induce leukemia gene expression in cord blood hematopoietic stem cells expanded ex vivo.
Lam YM; Chan YF; Chan LC; Ng RK
Int J Hematol; 2017 Jan; 105(1):37-43. PubMed ID: 27531147
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
12. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
[TBL] [Abstract][Full Text] [Related]
13. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-mobilized peripheral blood CD34+Thy-1+Lin- human hematopoietic stem cells as target cells for transplantation-based gene therapy.
Chen BP; Fraser C; Reading C; Murray L; Uchida N; Galy A; Sasaki D; Tricot G; Jagannath S; Barlogie B
Leukemia; 1995 Oct; 9 Suppl 1():S17-25. PubMed ID: 7475307
[TBL] [Abstract][Full Text] [Related]
15. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells.
Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S
J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells.
Mahmud N; Petro B; Baluchamy S; Li X; Taioli S; Lavelle D; Quigley JG; Suphangul M; Araki H
Biol Blood Marrow Transplant; 2014 Apr; 20(4):480-9. PubMed ID: 24374212
[TBL] [Abstract][Full Text] [Related]
17. HOX decoy peptide enhances the ex vivo expansion of human umbilical cord blood CD34+ hematopoietic stem cells/hematopoietic progenitor cells.
Tanaka H; Matsumura I; Itoh K; Hatsuyama A; Shikamura M; Satoh Y; Heike T; Nakahata T; Kanakura Y
Stem Cells; 2006 Nov; 24(11):2592-602. PubMed ID: 17071861
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Different Cytokine Conditions Reveals Resveratrol as a New Molecule for Ex Vivo Cultivation of Cord Blood-Derived Hematopoietic Stem Cells.
Heinz N; Ehrnström B; Schambach A; Schwarzer A; Modlich U; Schiedlmeier B
Stem Cells Transl Med; 2015 Sep; 4(9):1064-72. PubMed ID: 26160960
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of quiescent cord blood stem/progenitor cells with high proliferative potential in stem-cell expansion culture.
Goussetis E; Theodosaki M; Paterakis G; Stefanaki K; Tsecoura C; Papassarandis C; Graphakos S
Cytotherapy; 2003; 5(6):500-8. PubMed ID: 14660046
[TBL] [Abstract][Full Text] [Related]
20. Highly efficient ex vivo expansion of human hematopoietic stem cells using Delta1-Fc chimeric protein.
Suzuki T; Yokoyama Y; Kumano K; Takanashi M; Kozuma S; Takato T; Nakahata T; Nishikawa M; Sakano S; Kurokawa M; Ogawa S; Chiba S
Stem Cells; 2006 Nov; 24(11):2456-65. PubMed ID: 16857897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
